Psychedelic therapy for addiction: balance between potency and caution

At Triptherapie, we are seeing an increasing number of clients registered with addiction problems. We are often asked whether a psychedelic session can help. We then ask what we experience in practice and what scientific studies demonstrate. In any case, we have seen good results, and a number of reviews can be found regarding this subject.

However, it is important to maintain a balance between enthusiasm and caution. The scientific literature shows interesting results, but the evidence is still limited, and many studies are small or methodologically complex. In this article, we look at what research shows and how this relates to client real-world experiences.

What does the scientific research say?

Research into psychedelics for addiction focuses primarily on psilocybin, LSD, and MDMA. Each of these substances has a different mechanism of action and is usually studied in combination with psychotherapy.

Psilocybin for alcohol addiction

One of the most important modern studies investigated psilocybin in people with alcohol addiction. In this randomized study, 95 participants received psychotherapy combined with two sessions of psilocybin or an active placebo.

After 32 weeks, it was found that the group receiving psilocybin had, on average, significantly fewer heavy drinking days than the control group. The percentage of participants who remained temporarily completely abstinent was also higher in the psilocybin group.

Although these results are promising, the study also had limitations. Many participants could guess whether they had received psilocybin or a placebo, meaning expectation effects may have played a role. Additionally, the study group was relatively small and consisted of motivated participants with intensive guidance.

Psilocybin for tobacco addiction

Regarding nicotine addiction, the results are striking, but also based on small studies. In a pilot study combining psilocybin with cognitive behavioral therapy, approximately 80 percent of participants were smoke-free after six months.

At a longer-term follow-up, it was found that a large proportion of the participants remained abstinent. This percentage is higher than in most traditional smoking cessation programs.

Because this study lacked a control group and worked with only fifteen participants, the effect may have been overestimated. Nevertheless, it indicates that psychedelic therapy could be an interesting direction for research.

LSD for alcohol addiction

LSD was already being investigated in the 1960s as an aid for alcohol addiction. A meta-analysis of six randomized studies showed that a single LSD session could increase the likelihood of improvement in alcohol abuse.

Approximately 59 percent of the participants in the LSD group showed improvement, compared to 38 percent in the control group. The effects appeared to be present mainly in the first months after the session.

Because these studies are old and methodologically less rigorous than modern studies, the results are usually considered low to moderate evidence.

MDMA for alcohol addiction

MDMA is primarily investigated for post-traumatic stress disorder, but there are also small studies on alcohol addiction. In a pilot study with fourteen participants, patients received two MDMA sessions combined with psychotherapy after detoxification.

At the follow-up nine months later, a large proportion of the participants were abstinent or drank significantly less alcohol than before. Because it was an open-label study without a control group and with a small sample size, these results should be interpreted with caution.

Safety and risks

In controlled research settings, psychedelics generally appear reasonably safe when participants are carefully screened and monitored. Serious side effects are rare, but mild side effects are relatively common.

Common acute reactions include headache, nausea, anxiety, or a temporary increase in blood pressure and heart rate. Some people may experience intense emotional or anxious experiences during the session.

Important risk groups are people with a personal or family history of psychosis or bipolar disorder. Interactions with certain medications, such as lithium or MAO inhibitors, can also increase risks. Therefore, such groups are usually excluded from scientific studies.

Practical experiences from Tripforum

In addition to scientific research, there are also practical experiences from people who have undergone psychedelic sessions under supervision. On Tripforum, clients share their experiences with sessions at Triptherapie.

Some examples:

Reset experience with alcohol and gambling
One participant described how a truffle session felt like a “reset button” was pressed. He indicated that after the session he no longer felt the need to drink alcohol or gamble and regained the motivation to live a healthier life.
https://tripforum.nl/recensie-truffel-therapie-marcel/reset-knop-aan-en-gaan/#post-462

Alcohol addiction
Another client reported that the craving for alcohol had disappeared after a truffle ceremony and that he felt more aware of his behavior and life choices.
https://tripforum.nl/recensie-truffel-therapie-marcel/truffelceremonie-tegen-alcoholverslaving/#post-1011

Stop smoking weed
A person who used cannabis daily for eight years indicated that after an individual truffle session, he hardly felt the need to smoke anymore. He also described fewer depressive feelings and less social anxiety.
https://tripforum.nl/recensie-truffel-therapie-marcel/recensie-truffel-ceremonie-individueel/#post-852

Cocaine addiction
In an English-language review, a participant states that after a psychedelic session, he felt that his cocaine cravings had disappeared and that he was entering a new phase in his life.
https://tripforum.nl/recensie-truffel-therapie-marcel/cocaine-addiction-gone-after-my-trip-therapy/

These stories show that some people experience profound changes after a psychedelic session. At the same time, these are personal experiences and not verified scientific data. Therefore, it is unclear how often such changes occur or how lasting they are in the long term.

A realistic conclusion

Current research into psychedelic therapy for addiction gives reason for cautious optimism. Psilocybin, in particular, shows clear reductions in alcohol use in several studies, and possibly also in nicotine addiction.

At the same time, most studies are small, methodologically complex, and often difficult to blind. As a result, expectation effects can play a role. Moreover, risk groups are usually excluded, meaning the results do not automatically apply to all people with addiction problems.

Our practical experience shows that some people actually quit smoking, alcohol, or even cocaine after a guided session. These stories are valuable, but they do not count as scientific proof.

Psychedelic therapy can therefore best be viewed as a potential tool within a broader therapeutic trajectory. Good preparation, professional guidance, post-treatment integration, and medical screening are important components. It can also be examined whether certain combinations with psychedelic sessions, such as supplements and other lifestyle improvements, increase the chance of success. Consider, for example, GABA, DHEA and psilocybin together.

More large-scale and long-term research is needed to determine for whom this form of therapy is most effective and safe. Until then, it is wise to take both the potential and the limitations of psychedelic therapy seriously.